ARCHIVES

Gleevec Approval Sets Record For FDA Review: 73 Days

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

16 Institutions Win NCI Awards for Phase I Trials

May 2, 2003

Coffey Presses NCI BSA chairman David Linvingston On support For Increase In NCI Budget

April 25, 1997

Approval Granted For New Formulation of Lupron Depot

July 29, 2011

Letters: Broder Response To Waxman Called Political Back-Pedaling

February 11, 1994

ACCC To Present Program On Impact Of New Technology

January 23, 1981

Colorectal, Lung Cancer Screening Techniques Show No Mortality Improvement, Conferences Find

December 1, 1978